BUSINESS COMBINATION (Details 1) - USD ($) $ in Thousands		1 Months Ended
		Jun. 19, 2013	Dec. 31, 2015	Dec. 31, 2014
Total purchase consideration		$ 29,795
Assets acquired
Cash and cash equivalents		18,198
Restricted cash		2,260
Testosterone Gel NDA	[1]	10,900
Other tangible assets		79
Deferred tax assets, net		0
Goodwill		1,838	$ 1,838	$ 1,838
Total assets		33,275
Liabilities assumed
Accrued severance		2,965
Other liabilities		515
Total liabilities		3,480
Total net assets acquired		$ 29,795

[1] As part of the Merger, we acquired a testosterone gel product that was licensed to Teva (the "Testosterone Gel NDA"). In May 2015, we acquired from Teva the approved New Drug Application ("NDA") for the previously-licensed product (Note 6).